Tag:

Reverse Medical Corporation

Latest Headlines

Reverse Medical lands $14M in Series B

March 30, 2010

Reverse Medical Corporation has raised $14 million in a Series B private equity financing. New investors Wexford Capital, Getz Bros., BioStar Ventures, Early Stage Partners and Emergent Medical

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
HTA in Medtech - Free SymposiumSaturday, June 2, 2012 — ISPOR Washington
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe

MORE EVENTS

Press Releases

Featured Jobs

Project Manager, Marketing Excellence Job
Celgene Corporation - Summit, NJ, US
District Sales Manager
Vivus, Inc. -
Sr. Director/Executive Director of Operations, Inflammation and Immunology CRD Job
Celgene Corporation - Tokyo, Ja, US
Statistician Job
Yoh - Montville, NJ, USA
Director, Regulatory Affairs
Tesaro - Waltham, MA

Reverse Medical Corporation

Latest Headlines

Latest Headlines

Reverse Medical lands $14M in Series B

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

Reverse Medical Corporation

Latest Headlines

Latest Headlines

Reverse Medical lands $14M in Series B

Related Tags